Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study

被引:1276
|
作者
Knochenhauer, ES
Key, TJ
Kahsar-Miller, M
Waggoner, W
Boots, LR
Azziz, R
机构
[1] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Dept Occupat Hlth, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA
[4] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA
来源
关键词
D O I
10.1210/jc.83.9.3078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estimates of the prevalence of the polycystic ovary syndrome (PCOS) in the general population have ranged from 2-20%. The vast majority of these reports have studied White populations in Europe, used limited definitions of the disorder, and/or used bias populations, such as those seeking medical care. To estimate the prevalence of this disorder in the United States and address these limitations, we prospectively determined the prevalence of PCOS in a reproductive-aged population of 369 consecutive women (174 White and 195 Black; aged 18-45 yr), examined at the time of their preemployment physical. Body measures were obtained, and body hair was quantified by a modified Ferriman-Gallwey (F-G) method. All exams were initially performed by 2 trained nurses, and any subject with an F-G score above 3 was reexamined by a physician, the same for all patients. Of the 369 women, 277 (75.1%) also agreed to complete a questionnaire and have additional blood drawn. Subjects were studied regardless of current estrogen/progestin hormonal use (28.5%). PCOS was defined as 1) oligoovulation, 2) clinical hyperandrogenism (i.e. hirsutism) and/or hyperandrogenemia, and 3) exclusion of other related disorders, such as hyperprolactinemia, thyroid abnormalities, and nonclassic adrenal hyperplasia. Hirsutism was defined by a F-G score of 6 or more, and hyperandrogenemia was defined as a total or free testosterone, androstenedione, and/or dehydroepiandrosterone sulfate level above the 95th percentile of control values [i,e, all eumenorrheic women in the study, who had no hirsutism (F-G less than or equal to 5) or acne and were receiving no hormonal therapy; n = 98]. Considering all 369 women studied, White and Black women had similar mean ages (29.4 +/- 7.1 and 31.1 +/- 7.8 yr, respectively), although White women had a lesser body mass than Black women (24.9 +/- 6.1 vs. 29.2 +/- 8.1 kg/m(2), respectively; P < 0.001). Of these 7.6%, 4.6%, and 1.98 demonstrated a F-G score of 6 or more, 8 or 10, respectively, and there was no significant racial difference, with hirsutism prevalences of 8.0%, 2.8%, and 1.6% in Whites, and 7.1%, 6.1%, and 2.1% in Blacks, respectively. Of the 277 women consenting to a history and hormonal evaluation, 4.0% had PCOS as defined, 4.7% (6 of 129) of Whites and 3.4% (5 of 148) of Blacks. In conclusion, in our consecutive population of unselected women the prevalence of hirsutism varied from 2-8% depending on the chosen cut-off F-G score, with no significant difference between White and Black women. Using an F-G score of 6 or more as indicative of hirsutism, 3.4% of Blacks and 4.7% of Whites had PCOS as defined. These data suggest that PCOS may be one of most common reproductive endocrinological disorders of women.
引用
收藏
页码:3078 / 3082
页数:5
相关论文
共 50 条
  • [31] Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
    Kyrkou, Giannoula
    Trakakis, Eftichios
    Attilakos, Achilleas
    Panagopoulos, Periklis
    Chrelias, Charalampos
    Papadimitriou, Anastasios
    Vaggopoulos, Vasilis
    Alexiou, Eleni
    Mastorakos, Georgios
    Lykeridou, Aikaterini
    Kassanos, Dimitrios
    Papaevangelou, Vasiliki
    Papantoniou, Nikolaos
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (04) : 915 - 923
  • [32] Valproate, polycystic ovary syndrome and the need for a prospective study
    Reuber, M
    Goulding, PJ
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2000, 9 (03): : 235 - 236
  • [33] Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study
    Mishra, Neha
    Verma, Ruchi
    Jadaun, Payal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [34] Prevalence of polycystic ovary syndrome in women in China: a large community-based study
    Li, Rong
    Zhang, Qiufang
    Yang, Dongzi
    Li, Shangwei
    Lu, Shulan
    Wu, Xiaoke
    Wei, Zhaolian
    Song, Xueru
    Wang, Xiuxia
    Fu, Shuxin
    Lin, Jinfang
    Zhu, Yimin
    Jiang, Yong
    Feng, Huai L.
    Qiao, Jie
    HUMAN REPRODUCTION, 2013, 28 (09) : 2562 - 2569
  • [35] Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study
    Palomba, Stefano
    Russo, Tiziana
    Orio, Francesco, Jr.
    Falbo, Angela
    Manguso, Francesco
    Sammartino, Annalidia
    Tolino, Achille
    Colao, Annamaria
    Carmina, Enrico
    Zullo, Fulvio
    HUMAN REPRODUCTION, 2006, 21 (11) : 2823 - 2829
  • [36] Comparison Of The Effects Of Atorvastatin And Simvastatin In Women With Polycystic Ovary Syndrome: A Prospective, Randomized Study
    Kaya, C.
    Pabuccu, R.
    Cengiz, S. D.
    Dunder, I.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (03) : 161 - 166
  • [37] The Effectiveness of Myo-Inositol in Women With Polycystic Ovary Syndrome: A Prospective Clinical Study
    Sharon, P. Minthami
    Mellonie, P.
    Manivannan, Anu
    Thangaraj, Priyanka
    Logeswari, B. M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [38] Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study
    Ladson, Gwinnett
    Dodson, William C.
    Sweet, Stephanie D.
    Archibong, Anthony E.
    Kunselman, Allen R.
    Demers, Laurence M.
    Williams, Nancy I.
    Coney, Ponjola
    Legro, Richard S.
    FERTILITY AND STERILITY, 2011, 96 (01) : 224 - U364
  • [39] Prevalence and predictors of the metabolic syndrome in Saudi women with polycystic ovary syndrome.
    Ardawi, M. S.
    Rouzi, A. A.
    FERTILITY AND STERILITY, 2006, 86 : S450 - S451
  • [40] Prevalence of the metabolic syndrome in women with polycystic ovary syndrome in R. Macedonia
    Boshku, Aleksandra Atanasova
    Panovska, Daniela Ivanova
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 131 - 132